NeuroFrontiers
By ReachMD
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by ReachMD
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 3
Reviews: 0
Episodes: 183
Description
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
| Episode | Date |
|---|---|
|
Understanding Variability in Myasthenia Gravis
|
May 01, 2026 |
|
Examining the Global Genetic Prevalence of TK2d
|
Apr 30, 2026 |
|
Advances in Cell-Based Therapy for MS
|
Apr 20, 2026 |
|
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
|
Apr 20, 2026 |
|
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
|
Mar 30, 2026 |
|
Proactive Pregnancy Planning and Reproductive Care in MS
|
Mar 30, 2026 |
|
Advancing Pediatric MS Care: Insights from AAN 2026
|
Mar 26, 2026 |
|
Updates in MS Care: Key Topics at AAN 2026
|
Mar 26, 2026 |
|
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
|
Feb 19, 2026 |
|
Understanding Accelerated Biological Aging in Pediatric MS
|
Feb 19, 2026 |
|
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
|
Feb 19, 2026 |
|
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
|
Jan 16, 2026 |
|
Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care
|
Dec 10, 2025 |
|
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
|
Sep 29, 2025 |
|
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
|
Sep 29, 2025 |
|
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
|
Sep 29, 2025 |
|
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
|
Sep 17, 2025 |
|
The Future of MS Management: Novel Agents and Clinical Approaches
|
Aug 26, 2025 |
|
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
|
Aug 20, 2025 |
|
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
|
Aug 20, 2025 |
|
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
|
Aug 19, 2025 |
|
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
|
Aug 14, 2025 |
|
Understanding MS: Managing Hidden and Overlooked Symptoms
|
Aug 14, 2025 |
|
Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
|
Aug 13, 2025 |
|
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
|
Jun 30, 2025 |
|
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
|
Jun 30, 2025 |
|
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
|
Jun 03, 2025 |
|
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
|
Jun 03, 2025 |
|
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
|
Jun 02, 2025 |
|
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
|
May 14, 2025 |
|
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
|
May 08, 2025 |
|
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
|
May 08, 2025 |
|
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
|
Apr 25, 2025 |
|
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
|
Apr 16, 2025 |
|
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
|
Apr 16, 2025 |
|
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
|
Apr 05, 2025 |
|
From Diagnosis to Treatment: Challenges in Glioblastoma Care
|
Apr 05, 2025 |
|
Climate Change in the Clinic: Examining Neurological Impacts
|
Apr 05, 2025 |
|
mIDH Gliomas Explained: Characteristics and Management Strategies
|
Apr 05, 2025 |
|
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
|
Mar 17, 2025 |
|
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
|
Mar 04, 2025 |
|
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
|
Mar 03, 2025 |
|
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
|
Feb 27, 2025 |
|
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
|
Feb 27, 2025 |
|
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
|
Feb 27, 2025 |
|
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
|
Feb 18, 2025 |
|
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
|
Feb 18, 2025 |
|
Navigating Myasthenia Gravis in Adolescents and Young Adults
|
Feb 04, 2025 |
|
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
|
Jan 28, 2025 |
|
FcRn Inhibitors: A Potential New Targeted Therapy Option
|
Jan 20, 2025 |
|
The Evolving gMG Treatment Landscape
|
Jan 20, 2025 |
|
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
|
Oct 22, 2024 |
|
Continuum of Care: Managing DMD in Pediatric and Adult Patients
|
Sep 11, 2024 |
|
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
|
Sep 11, 2024 |
|
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
|
Sep 10, 2024 |
|
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
|
Sep 04, 2024 |
|
The Impact of a cholesterol-lowering medication on Alzheimer’s Disease
|
Aug 29, 2024 |
|
How DDL-920 Could Help Restore Cognitive Function in Alzheimer’s Patients
|
Aug 28, 2024 |
|
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
|
Aug 22, 2024 |
|
Updates to the Diagnostic Criteria for MS Patients
|
Aug 02, 2024 |
|
The Impact of ECTRIMS Over 40 Years
|
Aug 02, 2024 |
|
Key Highlights from ECTRIMS 2024
|
Aug 02, 2024 |
|
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
|
Jul 02, 2024 |
|
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
|
Jul 02, 2024 |
|
Reviewing the Treatment Landscape for Duchenne Muscular Dystrophy
|
May 06, 2024 |
|
ADHD in Older Adults: Key Diagnostic and Treatment Strategies
|
Apr 24, 2024 |
|
Managing and Treating ADHD from Childhood to Adulthood
|
Apr 23, 2024 |
|
Exploring the Role of Nutrition in Managing Neurological Disorders
|
Apr 19, 2024 |
|
Differentiating the Diagnosis Between ADHD and Sleep Disorders
|
Apr 18, 2024 |
|
Understanding Pain Management in Children with Neurological Disorders
|
Apr 18, 2024 |
|
Helping Adult Patients Find the Right Treatment for ADHD Symptoms
|
Apr 17, 2024 |
|
Climate Change and Neurological Infections: The Effects Over Time
|
Apr 16, 2024 |
|
Managing Internal Medicine Issues in Hospitalized Neurological Patients
|
Apr 12, 2024 |
|
Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
|
Apr 12, 2024 |
|
Recognizing and Addressing Medical Gaslighting in Healthcare
|
Apr 10, 2024 |
|
Exploring the Clinical Treatments of Schizophrenia
|
Mar 27, 2024 |
|
The Role of Occupational Therapy in Schizophrenia Management
|
Mar 26, 2024 |
|
Investigating the Prevalence of Comorbidities in MS Clinical Trials
|
Mar 22, 2024 |
|
Assessing Disability in MS Patients with the SNRS and CombiWISE Tools
|
Mar 18, 2024 |
|
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
|
Mar 18, 2024 |
|
Practices for Preventing Polypharmacy in Multiple Sclerosis
|
Mar 13, 2024 |
|
Understanding the Cellular Basis for Altered Cognition in Schizophrenia
|
Mar 13, 2024 |
|
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
|
Mar 12, 2024 |
|
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
|
Mar 07, 2024 |
|
Exploring the Latest in MS Cognitive Rehabilitation Strategies
|
Mar 06, 2024 |
|
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
|
Mar 04, 2024 |
|
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
|
Mar 04, 2024 |
|
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
|
Mar 02, 2024 |
|
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
|
Feb 28, 2024 |
|
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
|
Feb 28, 2024 |
|
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
|
Feb 26, 2024 |
|
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
|
Feb 13, 2024 |
|
A Successful and Safe Stem Cell Therapy for Progressive MS
|
Feb 12, 2024 |
|
New Study Shows EBV-Specific T-Cells Contribute to MS Development
|
Feb 12, 2024 |
|
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
|
Feb 12, 2024 |
|
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
|
Feb 09, 2024 |
|
PBA Treatment May Reverse Signs of Alzheimer’s Disease
|
Feb 09, 2024 |
|
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
|
Jan 30, 2024 |
|
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
|
Nov 28, 2023 |
|
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
|
Nov 21, 2023 |
|
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
|
Nov 14, 2023 |
|
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
|
Nov 09, 2023 |
|
MS in Children: Exploring Biomarker Research Advancements
|
Oct 31, 2023 |
|
Discussing Disparities in MS Care for Underrepresented Populations
|
Oct 26, 2023 |
|
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
|
Sep 26, 2023 |
|
Highlights from the 2023 Psych Congress
|
Sep 08, 2023 |
|
Diagnosing Suspected MS: A Review of the Updated Guidelines
|
Sep 01, 2023 |
|
Studying the Safety of Discontinuing DMTs in MS Older Adults
|
Aug 17, 2023 |
|
Uncovering Disease Progression in Multiple Sclerosis
|
Aug 13, 2023 |
|
Examining the Correlation Between HIV & Neurocognitive Disorders
|
Jul 26, 2023 |
|
Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
|
Jul 18, 2023 |
|
NIH Study Identifies Cause for Long COVID Neurological Symptoms
|
Jul 12, 2023 |
|
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
|
May 31, 2023 |
|
Combating Controversies in BPSD Care
|
May 30, 2023 |
|
The Cell Death Pathway: Leveraging Glioblastoma Treatments
|
May 17, 2023 |
|
Treating BPSD with Cannabinoids: What We Currently Know
|
May 17, 2023 |
|
What to Expect at the 2023 APA Annual Meeting
|
May 17, 2023 |
|
Seizures & Epilepsy: How Cell Phone Videos Could be an Effective Tool
|
Mar 09, 2023 |
|
A Look at Lecanemab: The Latest Breakthrough in Alzheimer’s Treatment
|
Feb 22, 2023 |
|
First Responders with PTSD: Exploring the Neurological Underpinnings
|
Jan 25, 2023 |
|
Childhood-Onset Epilepsy: A Look into the Effects of Aging
|
Dec 29, 2022 |
|
The Impact of Individual Autonomic Domains in Parkinson’s Disease
|
Dec 20, 2022 |
|
Treating Trauma with EMDR Therapy
|
Oct 26, 2022 |
|
Diving into the Genetic Pathway: A Look at the STING Pathway & Brain Cancer
|
Oct 12, 2022 |
|
Exploring New Research on Melanoma Brain Metastases
|
Sep 28, 2022 |
|
Discovering Face Blindness: An Expert’s Perspective on Prosopagnosia
|
Aug 30, 2022 |
|
Advances in Temporal Lobe Epilepsy Research
|
Aug 29, 2022 |
|
AI in Neurology: What Tools Are Emerging?
|
Jun 30, 2022 |
|
Clinical Considerations for the Treatment of Schizophrenia
|
Jun 07, 2022 |
|
Investigating the Link Between Hypertension Medications & Dementia
|
May 23, 2022 |
|
B-Cell Therapy: When Is It Right for Our MS Patients?
|
May 19, 2022 |
|
Alzheimer’s Disease: What’s The Latest Research?
|
Apr 26, 2022 |
|
Diving into the Debate Surrounding Aducanumab for Alzheimer’s
|
Apr 20, 2022 |
|
Keys to Closing the Gender Gap in Stroke Trials
|
Mar 14, 2022 |
|
Diagnosing Mental Illness with the Perspectives Approach
|
Feb 18, 2022 |
|
Reducing Relapse for Schizophrenia Patients: A Look at LAI Antipsychotics
|
Jan 07, 2022 |
|
Tracking Transition Readiness & Quality of Life Among Pediatric MS Patients
|
Dec 27, 2021 |
|
The Importance of Collaboration in MS Care: Takeaways from CMSC
|
Dec 16, 2021 |
|
A Recap of the Rehabilitation Track at CMSC
|
Dec 16, 2021 |
|
What to Know About Post-COVID-19 Neurological Syndrome
|
Dec 07, 2021 |
|
Could T Cells Lead to New MS Treatments?
|
Oct 26, 2021 |
|
Caring for Treatment-Resistant Schizophrenia: Is DBS the Answer?
|
Oct 01, 2021 |
|
What to Consider When Treating Transgender Patients with Epilepsy
|
Sep 10, 2021 |
|
Women & Mental Health: Taking a Targeted Treatment Approach
|
Jun 14, 2021 |
|
Uncovering Unknowns in TBI: An Exploration of Manifestations in Women
|
Jun 10, 2021 |
|
Real-Time Dialogue with Dreamers: An Exploration of Communication During REM Sleep
|
May 13, 2021 |
|
Understanding the Brain: An Exploration of an Extraordinary Organ
|
May 13, 2021 |
|
The Dangers of a Broken Heart: Collaborating on Cardiomyopathy
|
Apr 01, 2021 |
|
Deep Brain Stimulation in the OR: What Neurologists & Patients Can Expect
|
Mar 31, 2021 |
|
Investigating Impulses: A Look at Deep Brain Stimulation
|
Mar 31, 2021 |
|
Exploring the Evolving Landscape in Managing Multiple Sclerosis
|
Mar 29, 2021 |
|
Expanding on the Neurologic Effects of COVID-19
|
Mar 26, 2021 |
|
Seeking Out Symptoms of Broken Heart Syndrome
|
Mar 26, 2021 |
|
Shedding Light on the Brain After COVID-19: Assessing the Spectrum of Neurological Risk
|
Mar 26, 2021 |
|
Refocusing Our Efforts on Advancing Technology to Help Stroke Survivors
|
Mar 19, 2021 |
|
The Future of Restoring Functionality in Stroke Survivors
|
Mar 19, 2021 |
|
Pressing Play: Do Video Games Have a Role in Healthcare?
|
Mar 17, 2021 |
|
Investigating the Variants of the COVID-19 Virus
|
Mar 16, 2021 |
|
How Does COVID-19 Affect the Mind?
|
Mar 16, 2021 |
|
Evaluating the Evolving Field of Fetal Neurology
|
Jan 26, 2021 |
|
Spotlight on Meningiomas: Risks and Clinical Manifestations
|
Sep 14, 2011 |
|
A New Game Plan for Treating Concussions
|
Sep 14, 2011 |
|
Treating Diabetic Nerve Pain: Guidelines from the American Academy of Neurology
|
Sep 14, 2011 |
|
How Smart Phones Are Improving Neurologic Care
|
Sep 14, 2011 |
|
The Doctor Will See All of You Now: New Approaches to Treating Parkinson's Disease
|
Sep 14, 2011 |
|
How to Help Patients Cope With Loss of Taste and Smell
|
Feb 23, 2011 |
|
Emerging New Therapies for Multiple Sclerosis Patients
|
Feb 23, 2011 |
|
Updated Guidelines for Brain Death and the Impact on Organ Donation
|
Feb 23, 2011 |
|
Solving the Mystery of Restless Leg Syndrome
|
Feb 23, 2011 |
|
Strategies to Improve Critical Care of a Gunshot Wound to the Head
|
Feb 17, 2011 |
|
Repurposing Botulinum Toxin as Treatment for Chronic Migraines
|
Feb 17, 2011 |
|
Alzheimer's and Driving: When It's Time to Take the Keys
|
Feb 17, 2011 |
|
Dispatches From the Haiti Earthquake Relief
|
Mar 04, 2010 |
|
Guillain-Barre Syndrome and the H1N1 Vaccine in Context
|
Nov 11, 2009 |
|
Expanded Window of Time for Treating Stroke
|
Nov 11, 2009 |
|
Novel Thinking in Alzheimer’s Screening and Treatment
|
Jul 14, 2009 |
|
The Dizzy Patient: Recommended Therapies for Vertigo
|
Jun 24, 2009 |
|
Sudden Death in Sports
|
Jun 24, 2009 |
|
Diagnosis and Treatment of Multiple Sclerosis
|
Jun 24, 2009 |
|
Chronic Neuropathic Pain and Peripheral Neuropathy
|
Dec 17, 2008 |
|
Research Innovations in Pediatric Migraines
|
Dec 17, 2008 |
|
Vascular Risks of Migraines
|
Dec 17, 2008 |
|
Epilepsy Drug Substitution and Epilepsy Drugs in Pregnancy
|
Dec 17, 2008 |